// App-Quantinova.ai

548 : Treatment of Stage I-II A Non-Bulky Hodgkin's Lymphoma (HL): An Individual Patient-Data Comparison of German Hodgkin Study Group (GHSG) HD10 and HD11 Combined-Modality Therapy (CMT) and NCIC Clinical Trials Group (NCIC CTG) HD.6 ABVD Alone

Researchers

Presenter

  • Beate Klimm

Principal Investigators

  • Andreas Lohri

  • Jane N. Winter

  • Bernd Dorken

  • Robert G. Pearcey

  • Volker Diehl

  • Sandra J. Horning

  • Hans Theodor Eich

  • Andreas Engert

  • Ralph M. Meyer

  • Helen Goergen

  • Lois E. Shepherd

  • Michael Fuchs

  • Mary Gospodarowicz

  • Peter Borchmann

  • Joseph M. Connors

  • Jana Markova

  • Michael Crump

Medical Centers

  • Northwestern University, Feinberg School of Medicine, Chicago, IL

  • German Hodgkin Study Group (GHSG), Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany

  • Pathology and Molecular Medicine, NCIC Clinical Trials Group - Quee-s University, Kingston, ON, Canada

  • Department of Hematology and Oncology, University Hospital, Rostock, Germany

  • Deptartment of Oncology/Hematology, Medical University Clinic, Liestal, Switzerland

  • Cancer Research Institute, Queen's University, Kingston, ON, Canada

  • First Department of Internal Medicine, University Hospital Cologne, German Hodgkin Study Group (GHSG), Cologne, Germany

  • Radiation Oncology, UHN-Princess Margaret Hospital, Toronto, ON, Canada

  • First Department of Internal Medicine, German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany

  • First Department of Internal Medicine, German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany

  • Department of Oncology, Cross Cancer Institute, Edmonton, AB, Canada

  • Department of Clinical Hematology, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic

  • Molekulares Krebsforschungszentrum MKFZ, Charite - Universitatsmedizin Berlin, Berlin, Germany

  • Biostatistics, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

  • Quee-s University, NCIC Clinical Trials Group, Kingston, ON, Canada

  • Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  • Quee-s University, NCIC Clinical Trials Group, Kingston, ON, Canada

Locations

  • Canada

  • Czech Republic

  • Germany

  • Switzerland

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

  • Mediastinal mass

  • Lymphomas

Biomarkers

  • Estrogen receptor alpha

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved